BDBM274944 4-{[(3R,6R)-6- methyl-1- {[2-(2H-tetrazol-2- yl)phenyl]carbonyl}- piperidin-3-yl]oxy}- furo[3,4- c]pyridin-1(3H)- one::US9556190, Example 34

SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1nccc2C(=O)OCc12

InChI Key InChIKey=CWBILHOJQKXDKS-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 274944   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM274944(4-{[(3R,6R)-6- methyl-1- {[2-(2H-tetrazol-2- yl)ph...)
Affinity DataIC50: 30nMAssay Description: In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2018
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM274944(4-{[(3R,6R)-6- methyl-1- {[2-(2H-tetrazol-2- yl)ph...)
Affinity DataIC50: 1.00E+4nMAssay Description: In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2018
Entry Details
Go to US Patent